National governments require economic data on the burden of influenza disease, the cost effectiveness of the vaccine, and the projected implementation costs of a maternal influenza immunization programme in their country in order to inform the allocation of limited resources and prioritization of interventions in the health sector. To support decision making and implementation efforts in countries, WHO has developed the Economic Value Chain for Influenza Vaccination.